Product Name | Clozapine N-oxide |
Description |
Activator of DREADDs |
Purity | >98% (TLC); NMR (Conforms) |
CAS No. | 34233-69-7 |
Molecular Formula | C18H19ClN4O |
Molecular Weight | 342.8 |
Field of Use | Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only. |
Storage Temperature | -20ºC |
Shipping Temperature | Shipped Ambient |
Product Type | Activator |
Solubility | May be dissolved in DMSO (15 mg/ml); or ethanol (3 mg/ml) |
Source | Synthetic |
Appearance | Yellow powder |
SMILES | ClC(C=C3)=CC1=C3NC(C=CC=C2)=C2C(N4CC[N+](C)([O-])CC4)=N1 |
InChI | InChI=1S/C18H19ClN4O/c1-23(24)10-8-22(9-11-23)18-14-4-2-3-5-15(14)20-16-7-6-13(19)12-17(16)21-18/h2-7,12,20H,8-11H2,1H3 |
InChIKey | WYRDWWAASBTJLM-UHFFFAOYSA-N |
Safety Phrases | GHS Classification: GHS06 Acute toxicity (oral, dermal, inhalation), categories 1,2,3 Hazard statement(s): H301-H336 |
Cite This Product | Clozapine N-oxide (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SIH-570) |
Alternative Names | 8-Chloro-11-(4-methyl-4-oxido-1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine |
Research Areas | Cell Signaling, G Protein Signaling, GPCR, Neuroscience, Neurotransmission |
PubChem ID | 2819 |
Scientific Background | Clozapine N-Oxide is an agonist at human muscarinic designer receptors known as DREADDs. |
Reviews
There are no reviews yet.